Aztreonam penetration into synovial fluid and bone.

AUTOR(ES)

MacLeod, C M

RESUMO

Eighteen patients with uncomplicated degenerative joint disease requiring joint replacement (hip or knee) were given a single 2-g intravenous dose of aztreonam over a 5-min period preoperatively. The mean concentration in synovial fluid of 83.0 +/- 9.2 micrograms/ml averaged 0.99 times the concomitant levels in serum. The mean concentration in cancellous bone of 16.0 +/- 4.3 micrograms/g averaged 0.20 times the concomitant levels in serum.

Documentos Relacionados

• Gentamicin and Tobramycin Penetration into Synovial Fluid
• Penetration of cefazolin into normal and osteomyelitic canine cortical bone.
• Comparative penetration of metronidazole, clindamycin, chloramphenicol, cefoxitin, ticarcillin, and moxalactam into bone.
• Penetration of aztreonam into cerebrospinal fluid of patients with bacterial meningitis.
• Penetration of aztreonam into cerebrospinal fluid of patients with and without inflamed meninges.